| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 02/16/2000 | EP0979208A1 Composition and method for reducing copper oxide to metallic copper |
| 02/16/2000 | EP0979064A1 Oxidation colorants |
| 02/16/2000 | CN1049432C Method for prepn. of morpholine compound |
| 02/15/2000 | US6025493 For treatment of psychological disorders, alzheimer's disease, parkinson's disease, nervous system disorders |
| 02/15/2000 | US6025382 Antithrombotic diamines |
| 02/15/2000 | US6025359 Drug resistance and multidrug resistance modulators |
| 02/15/2000 | US6025029 Storage stable, humidity curing adhesives |
| 02/10/2000 | WO2000006559A1 Reduced dipeptide analogues as calcium channel antagonists |
| 02/10/2000 | WO2000006558A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 02/10/2000 | WO2000006537A1 N-substituted sulfonamide derivatives |
| 02/10/2000 | WO2000006535A1 Tyrosine-derived compounds as calcium channel antagonists |
| 02/10/2000 | WO2000006531A2 Nitric esters and nitrate salts of specific drugs |
| 02/10/2000 | WO2000006529A1 Diketoacid-derivatives as inhibitors of polymerases |
| 02/10/2000 | WO2000006254A2 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 02/10/2000 | WO2000006153A1 Propenamides as ccr5 modulators |
| 02/10/2000 | WO2000006148A1 Sulphonamide derivatives |
| 02/10/2000 | WO2000006146A1 Substituted anilide compounds and methods |
| 02/10/2000 | WO2000006145A1 Methods for treating conditions modulated by lactosylceramide |
| 02/10/2000 | WO2000006140A2 Use of moclobemide for treating certain phsychiatric and medical disorders |
| 02/10/2000 | WO2000006139A2 Use of moclobemide and metabolites for treating and preventing substance abuse |
| 02/10/2000 | WO2000006138A2 Use of moclobemide for treating pain and other diseases |
| 02/10/2000 | WO2000006137A2 Glucocorticoid-selective anti-inflammatory agents |
| 02/10/2000 | WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors |
| 02/10/2000 | CA2339091A1 Sulphonamide derivatives |
| 02/10/2000 | CA2338804A1 Propenamides as ccr5 modulators |
| 02/10/2000 | CA2338764A1 Substituted anilide compounds and methods |
| 02/10/2000 | CA2338694A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 02/10/2000 | CA2338490A1 Diketoacid-derivatives as inhibitors of polymerases |
| 02/10/2000 | CA2338330A1 Use of moclobemide for treating certain phsychiatric and medical disorders |
| 02/10/2000 | CA2338327A1 Use of moclobemide for treating pain and other diseases |
| 02/10/2000 | CA2338326A1 Use of moclobemide and metabolites for treating and preventing substance abuse |
| 02/10/2000 | CA2336549A1 Methods for treating conditions modulated by lactosylceramide |
| 02/09/2000 | EP0978512A1 Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications |
| 02/09/2000 | EP0977756A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 02/09/2000 | EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 02/09/2000 | EP0977730A1 Amino acid derivatives inhibiting extracellular matrix metalloproteinase and tnf alpha release |
| 02/09/2000 | EP0977571A1 Piperazine derivatives for treating bone deficit conditions |
| 02/09/2000 | CN1244175A Mixed peroxygen activator compositions |
| 02/09/2000 | CN1244174A Liquid compositions containing N-Alkyl ammonium acetonitrile salts |
| 02/08/2000 | US6022996 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 02/08/2000 | US6022969 Symmetrical bis(aminoalkyl), bis(amidinoalkyl) and bis(guanidinoalkyl) cycloalkanes |
| 02/08/2000 | US6022906 α-aminoacetophenone photoinitiators |
| 02/08/2000 | US6022898 Metalloproteinase inhibitors |
| 02/08/2000 | US6022874 Piperazine based cytofectins |
| 02/08/2000 | US6022873 Metalloproteinase inhibitors |
| 02/06/2000 | CA2279747A1 Estrogen agonists/antagonists |
| 02/03/2000 | WO2000005225A1 Biphenyl derivatives |
| 02/03/2000 | WO2000005210A1 N,n-substituted cyclic amine derivatives |
| 02/03/2000 | WO2000005201A1 N-benzocycloalkyl-amide derivatives and their use as medicaments |
| 02/03/2000 | WO2000005198A1 Anthranilic acid derivatives |
| 02/03/2000 | WO2000005184A1 Method for hydrogenating unsaturated heterocyclic compounds |
| 02/03/2000 | WO2000004954A2 Novel urokinase inhibitors |
| 02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
| 02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 02/03/2000 | CA2338209A1 Biphenyl derivatives |
| 02/03/2000 | CA2338198A1 N-benzocycloalkyl-amide derivatives and their use as medicaments |
| 02/03/2000 | CA2337941A1 N,n-substituted cyclic amine compounds |
| 02/02/2000 | EP0976732A1 1,4-substituted cyclic amine derivatives |
| 02/02/2000 | EP0976722A1 Benzamidine derivatives |
| 02/02/2000 | EP0975625A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/02/2000 | EP0975614A1 A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity |
| 02/02/2000 | EP0975585A1 Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides |
| 02/02/2000 | EP0975583A1 Aromatic amides, their preparation process and their use as pesticides |
| 02/02/2000 | EP0863915B1 Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides |
| 02/02/2000 | CN1243505A Benzamidine derivatives |
| 02/02/2000 | CN1048982C Method for semi-synthesis of taxalkane derivative with metal alkane oxide and beta-lactum |
| 02/01/2000 | US6020519 Diphenyl-cyclopropenes as selective K-agonists |
| 02/01/2000 | US6020513 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 02/01/2000 | US6020368 Microbiocides |
| 02/01/2000 | US6020349 Constrained somatostatin agonists and antagonists |
| 02/01/2000 | US6020332 Fluorine-containing diphenyl acrylamide antimicrobial agents |
| 02/01/2000 | US6020317 Glycerol derivative, device and pharmaceutical composition |
| 02/01/2000 | US6019957 Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging |
| 02/01/2000 | CA2187542C Adamantane derivative, process for producing the same, and use thereof |
| 01/27/2000 | WO2000004012A1 COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF |
| 01/27/2000 | WO2000003975A2 Aryl vinyl ether derivatives and their use as herbicides |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/27/2000 | WO1999058517A3 Isocyanate derivatizing agent and methods of production and use |
| 01/27/2000 | DE19832810A1 Hydrogenation of unsaturated heterocyclic compounds, especially pyridine compounds, uses a catalyst containing a Subgroup VIII metal on a macroporous support |
| 01/27/2000 | CA2338037A1 Compounds specific for the human .alpha.1d adrenergic receptor and uses thereof |
| 01/26/2000 | EP0974573A1 Phenylpropenone compounds and medicines containing the same |
| 01/26/2000 | EP0973780A1 Antibacterial substituted 7-acylamino -3-(methylhydrazono) methyl-cephalosporins and intermediates |
| 01/26/2000 | EP0973763A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 01/26/2000 | EP0973737A1 Efficient synthesis of a chiral mediator |
| 01/26/2000 | EP0973730A1 Calcilytic compounds |
| 01/26/2000 | EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 01/26/2000 | EP0800511B1 Functionalised photoinitiators, derivatives and macromers therefrom and their use |
| 01/26/2000 | EP0773920B1 2-(2,4,6-trimethyl phenyl)cyclopentane-1,3-dione derivatives |
| 01/26/2000 | CN1048722C (S) (+)-2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbonylmethyl]-benzoic acid pharmaceutical compositions contg. same, and process for prepn. |
| 01/26/2000 | CN1048719C Novel 7-(substituted)-8-(substituted)-9-(substituted amino)-6-demethyl-6-deoxytetracyclines, prepn. method, their compositions and use thereof |
| 01/25/2000 | US6018048 Noble metal Raney catalysts and preparation of hydrogenated compounds therewith |
| 01/25/2000 | US6017928 Retroviral protease inhibiting compounds |
| 01/25/2000 | US6017919 Compounds and pharmaceutical use thereof |
| 01/25/2000 | US6017918 Phenyl glycine compounds and methods of treating atherosclerosis and restenosis |
| 01/25/2000 | US6017917 Guanidine derivatives |
| 01/25/2000 | US6017464 Dimeric N-alkyl ammonium acetonitrile bleach activators |
| 01/25/2000 | CA2091994C Complexes of nitric oxide with polyamines |
| 01/25/2000 | CA2001436C Carboxylic acid derivatives |
| 01/20/2000 | WO2000002991A1 Amine reaction compounds comprising one or more active ingredient |